Brief news reports on Tuberculosis

With third-highest TB burden, South Africa is critical player in search for vaccine

The following is a guest post by  Jim Connolly,  president and CEO of Aeras, a nonprofit product development partnership dedicated to the development of tuberculosis vaccines. Aeras is located in Rockville, MD and operates an office in Cape Town, South Africa. 

Read More →

Recognizing excellence in the fight against childhood TB: Kochon Prize calls for nominations

Nominations for the 2012 Stop TB Partnership-Kochon Prize are being accepted until 1 September 2012. Funded by the Kochon Foundation, a non-profit foundation registered in the Republic of Korea, the US$ 65 000 prize is awarded once a year to persons, institutions, or organizations that have made a highly significant contribution to combating tuberculosis (TB).

Read More →

Invitation to attend TAC and MSF workshop during the Peoples Health Assembly

When: 14:30 – 16:30, Sunday 8 July 2012
Where: Peoples Health Assembly, The University of the Western Cape (UWC), Room TBA
Attendance open to all registered participants of the PHA

Read More →

Call for proposals: Early clinical development of new, promising TB vaccine candidates

TBVI has opened the following Call for proposals:
Deadline:  17:00 CEST, 11 September 2012

Read More →

7th South African HIV & TB Drug Resistance and Treatment Monitoring Workshop

The Southern Africa Treatment and Resistance Network (SATuRN) training programme invite you to participate in the 7th South African HIV & TB Drug Resistance and Treatment Monitoring Workshop. This workshop is funded in collaboration with the Free State Initiative on Resistance, Surveillance, and Treatment (FIRST) Study, a research project funded by European Union and the International Development Research Center (IDRC), the University of the Western Cape CDC/PEPFAR program, the Africa Centre/CAPRISA CDC program.

Read More →

Partnership to speed tuberculosis drug discovery

Seven pharmaceutical companies and four research institutions including Weill Cornell Medical College, working with the Bill & Melinda Gates Foundation, have launched an innovative partnership that aims to speed the discovery of essential new treatments for tuberculosis (TB).

Read More →

Europeans to fight tuberculosis with innovative technique

A European team of scientists is working on making new tuberculosis treatments a reality by developing better diagnostic imaging technology. The study is supported by the PREDICT-TB ('Model-based preclinical development of anti-tuberculosis drug combinations') project, which has clinched almost EUR 14.8 million from the Innovative Medicines Initiative (IMI) under the EU's Seventh Framework Programme (FP7). IMI is a public-private partnership between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Read More →

The TB Europe Coalition organizes a symposium

The TB Europe Coalition organizes a symposium during the Union Regional Conference on Tuberculosis and Lung Diseases in London on 5 July from 2-5pm.

Read More →

Stop TB Partnership welcomes India’s ruling on serological tests

In a welcome development, the central government of India has prohibited the manufacture for sale, distribution and use of serodiagnostic test kits for diagnosis of tuberculosis (TB).

Read More →

Blow to SA drugs sector as red tape snares trials

CAPE TOWN — QdotPharma, the only South African-owned clinical research organisation able to do "first in man" drug studies, has closed its doors, citing delays in project approvals by the Medicines Control Council (MCC).

Read More →

Page 562 of 632 · Total posts: 10

←First 561 562 563 Last→